Announcement
·
09 Dec 2025
·
M42’s IROS Partners with BioSapien to Advance Precision Oncology Clinical Trials in the UAE
Learn More

A New Dawn in Fertility: Embracing Innovation in IVF

30 January 2024
Specialized Medical Fields

About the Speakers

  • Dr. Val Zvereff
    Laboratory Director at M42
  • Dr. Fawad Khan
    Program Lead of the Hereditary High Risk & Cancer Survivorship Programs at the Oncology Institute, Cleveland Clinic Abu Dhabi
  • Dr. Stephen Grobmyer
    Chairman of Oncology at Cleveland Clinic Abu Dhabi
  • Albarah El Khani
    Chief Operating Officer, Integrated Health Solutions, M42

    Watch Next